Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dina Johar

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 19, 2019
Fib-4 Predicts Early Hematological Adverse Events Induced by Interferon-Based Triple Therapy in Chronic Hepatitis C Virus PatientsMohamed F Montasser, Samy Zaky, Mohamed Salaheldin, et al.
Journal of Gastrointestinal Cancer|April 8, 2018
Evaluation of Fecal M2PK as a Diagnostic Marker in Colorectal CancerHisham K Dabbous, Yosry Abd El-Rahman Mohamed, Runia F El-Folly, et al.
Microbial Pathogenesis|September 7, 2018
New approach to differentiate primary from latent Toxoplasma gondii abortion through immunoglobulin and DNA interpretationAshraf M A Barakat, Sylvia O Ahmed, Mona S Zaki, et al.
Archivum Immunologiae Et Therapiae Experimentalis|May 2, 2006
Monoclonal and bispecific antibodies as novel therapeuticsEvan P Booy, Dina Johar, Srilekha Maddika, et al.
Journal of Gastrointestinal Cancer|April 7, 2018
Significance of Glypican-3 in Early Detection of Hepatocellular Carcinoma in Cirrhotic PatientsAhmed M Tahon, Magdy Z El-Ghanam, Samy Zaky, et al.
Frontiers in Immunology|November 16, 2020
Diagnosis and Management of Hematological Adverse Events Induced by Immune Checkpoint Inhibitors: A Systematic ReviewNabil E Omar, Kareem A El-Fass, Abdelrahman I Abushouk, et al.
Seminars in Cancer Biology|August 18, 2019
Nanomedicine as a putative approach for active targeting of hepatocellular carcinomaMuhammed H Elnaggar, Abdelrahman I Abushouk, Ahmed H E Hassan, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|May 1, 2019
Diabetes-induced Proteome Changes Throughout DevelopmentDina Johar, Sara M Ahmed, Samer El Hayek, et al.
Seminars in Cancer Biology|June 2, 2019
Novel therapeutic strategies for spinal osteosarcomasM Akhtar Anwar, Chirine El-Baba, Muhammed H Elnaggar, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 19, 2019
Fib-4 Predicts Early Hematological Adverse Events Induced by Interferon-Based Triple Therapy in Chronic Hepatitis C Virus PatientsMohamed F Montasser, Samy Zaky, Mohamed Salaheldin, et al.
Journal of Gastrointestinal Cancer|April 8, 2018
Evaluation of Fecal M2PK as a Diagnostic Marker in Colorectal CancerHisham K Dabbous, Yosry Abd El-Rahman Mohamed, Runia F El-Folly, et al.
Microbial Pathogenesis|September 7, 2018
New approach to differentiate primary from latent Toxoplasma gondii abortion through immunoglobulin and DNA interpretationAshraf M A Barakat, Sylvia O Ahmed, Mona S Zaki, et al.
Archivum Immunologiae Et Therapiae Experimentalis|May 2, 2006
Monoclonal and bispecific antibodies as novel therapeuticsEvan P Booy, Dina Johar, Srilekha Maddika, et al.
Journal of Gastrointestinal Cancer|April 7, 2018
Significance of Glypican-3 in Early Detection of Hepatocellular Carcinoma in Cirrhotic PatientsAhmed M Tahon, Magdy Z El-Ghanam, Samy Zaky, et al.
Frontiers in Immunology|November 16, 2020
Diagnosis and Management of Hematological Adverse Events Induced by Immune Checkpoint Inhibitors: A Systematic ReviewNabil E Omar, Kareem A El-Fass, Abdelrahman I Abushouk, et al.
Seminars in Cancer Biology|August 18, 2019
Nanomedicine as a putative approach for active targeting of hepatocellular carcinomaMuhammed H Elnaggar, Abdelrahman I Abushouk, Ahmed H E Hassan, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|May 1, 2019
Diabetes-induced Proteome Changes Throughout DevelopmentDina Johar, Sara M Ahmed, Samer El Hayek, et al.
Seminars in Cancer Biology|June 2, 2019
Novel therapeutic strategies for spinal osteosarcomasM Akhtar Anwar, Chirine El-Baba, Muhammed H Elnaggar, et al.
Pageof 3